United States vs Uruguay: Immunization, measles second dose (% of children by the nationally)
United States
95.0%
in 2024
Uruguay
95.0%
in 2024
United States rank
33rd
Uruguay rank
33rd
Immunization, measles second dose (% of children by the nationally) over time
- United States
- Uruguay
How they compare
United States currently reports 95.0% against 95.0% in Uruguay, a difference of 0.0%.
The two have swapped places 4 times across 12 shared years of data; in 2013 it was Uruguay ahead.
United States ranks 33rd and Uruguay ranks 33rd of 178 countries.
United States has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | United States | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.3% | 93.1% | 0.1% | United States |
| 2020s | 95.0% | 90.0% | 5.0% | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, United States or Uruguay?
- United States, at 95.0% against 95.0% in Uruguay as of 2024.
- What is the difference in immunization, measles second dose between United States and Uruguay?
- 0.0%, with United States ahead.
- How many years of comparable data are there for United States and Uruguay?
- 12 years are reported by both, from 2013 to 2024.
- How do United States and Uruguay rank globally for immunization, measles second dose?
- United States ranks 33rd and Uruguay ranks 33rd of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.